FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Akihito Hiramatsu

Research Profile

Anatomy

Physiology

Disorders

Chemicals & Drugs

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Co-author Network

Publications

TOP 3
Mayuko Gotou; Ichiro Hanamura; Akihito Hiramatsu; Tomohiro Horio; Akira Imamura; Hidetsugu Mihara; Hiroshi Miwa; Shohei Mizuno; Hisao Nagoshi; Natsumi Sakamoto; Masato Shikami; Kazuto Suganuma; Miyuki Takahashi; Tomohiko Taki; Masafumi Taniwaki; Norikazu Tsunekawa; Motohiro Wakabayashi; Masaya Watarai; Hidesuke Yamamoto; Mineaki Goto; Masakazu Nitta
Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
Norikazu Imai; Hiroshi Miwa; Masato Shikami; Kazuto Suganuma; Mayuko Gotoh; Akihito Hiramatsu; Motohiro Wakabayashi; Masaya Watarai; Ichiro Hanamura; Akira Imamura; Hidetsugu Mihara; Kenya Shitara; Masabumi Shibuya; Masakazu Nitta
Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor.
Norikazu Imai; Masato Shikami; Hiroshi Miwa; Kazuto Suganuma; Akihito Hiramatsu; Masaya Watarai; Atsushi Satoh; Masato Itoh; Akira Imamura; Hidetsugu Mihara; Masakazu Nitta
t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Akihito Hiramatsu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mayuko Gotou; Ichiro Hanamura; Akihito Hiramatsu; Tomohiro Horio; Akira Imamura; Hidetsugu Mihara; Hiroshi Miwa; Shohei Mizuno; Hisao Nagoshi; Natsumi Sakamoto; Masato Shikami; Kazuto Suganuma; Miyuki Takahashi; Tomohiko Taki; Masafumi Taniwaki; Norikazu Tsunekawa; Motohiro Wakabayashi; Masaya Watarai; Hidesuke Yamamoto; Mineaki Goto; Masakazu Nitta
Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
Genes, chromosomes & cancer 2012;51(1):42-53.
2009: Norikazu Imai; Hiroshi Miwa; Masato Shikami; Kazuto Suganuma; Mayuko Gotoh; Akihito Hiramatsu; Motohiro Wakabayashi; Masaya Watarai; Ichiro Hanamura; Akira Imamura; Hidetsugu Mihara; Kenya Shitara; Masabumi Shibuya; Masakazu Nitta
Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor.
Leukemia research 2009;33(12):1650-7.
2006: Norikazu Imai; Masato Shikami; Hiroshi Miwa; Kazuto Suganuma; Akihito Hiramatsu; Masaya Watarai; Atsushi Satoh; Masato Itoh; Akira Imamura; Hidetsugu Mihara; Masakazu Nitta
t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.
British journal of haematology 2006;135(5):673-82.
2006: Akihito Hiramatsu; Hiroshi Miwa; Masato Shikami; Toshiko Ikai; Emi Tajima; Hidesuke Yamamoto; Norikazu Imai; Akiko Hattori; Taiichi Kyo; Masaya Watarai; Kazuhisa Miura; Atsushi Satoh; Masato Itoh; Akira Imamura; Hidetsugu Mihara; Yoshiro Katoh; Masakazu Nitta
Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.
Leukemia & lymphoma 2006;47(1):89-95.
2005: Toshiko Ikai; Hiroshi Miwa; Masato Shikami; Akihito Hiramatsu; Emi Tajima; Hidesuke Yamamoto; Norikazu Imai; Akiko Hattori; Kazuhiro Nishii; Kazuhisa Miura; Atsushi Satoh; Masato Itoh; Akira Imamura; Hidetsugu Mihara; Yoshiro Katoh; Masakazu Nitta
Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways.
European journal of haematology 2005;75(4):273-9.
2004: Motohiro Wakabayashi; Hiroshi Miwa; Masato Shikami; Akihito Hiramatsu; Toshiko Ikai; Emi Tajima; Hidesuke Yamamoto; Kazuhisa Miura; Atsushi Satoh; Masato Itoh; Akira Imamura; Hidetsugu Mihara; Yoshiro Katoh; Masakazu Nitta
Autocrine pathway of angiopoietins-Tie2 system in AML cells: association with phosphatidyl-inositol 3 kinase.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(4):353-60.
2004: Atsushi Satoh; Toshiko Ikai; Hiroshi Miwa; Norikazu Imai; Akihito Hiramatsu; Emi Tajima; Hidesuke Yamamoto; Motohiro Wakabayashi; Kazuhisa Miura; Masato Ito; Masato Shikami; Akira Imamura; Hidetsugu Mihara; Yoshiro Kato; Masakazu Nitta
Acute promyelocytic leukemia with drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.
Internal medicine (Tokyo, Japan) 2004;43(1):74-8.
2003: Atsushi Satoh; Hiroshi Miwa; Osami Daimaru; Norikazu Imai; Akihito Hiramatsu; Hidesuke Yamamoto; Masato Shikami; Akira Imamura; Hidetsugu Mihara; Masakazu Nitta
Aplastic anaemia associated with a Philadelphia chromosome and monosomy 7 during immunosuppressive therapy.
European journal of haematology 2003;71(2):130-2.
2002: Minori Kanakura; Hidetsugu Mihara; Motohiro Wakabayashi; Emi Tajima; Akihito Hiramatsu; Atsushi Sato; Akira Imamura; Hiroshi Miwa; Yoshiro Kato; Masakazu Nitta
[Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2002;91(3):1036-8.